Abstract

Based on the condensation reaction between amino groups of either cyclophosphamide or ifosphamide with the carbonyl group of ninhydrin, giving coloured and fluorescent products, a spectrophotometric procedure for both drugs is suggested in the range from 30 to 90μg ml−1 at 564 nm, with accuracies of 100.6 ± 1.06% and 100.8 ± 1.02% for cyclophosphamide and ifosphamide, respectively. Also, a spectrophotometric procedure for both drugs is proposed in the range from 1.2 to 3.6 μg ml−1 at 465 nm and 485 nm for cyclophosphamide and ifosphamide, respectively, using 380 nm as an excitation wavelength for both drugs with accuracies of 100.4 ± 1.83% and 99.5 ± 1.64%, respectively. This condensation reaction, however, does not differentiate between the two isomeric drugs. Another new method is, therefore, suggested. It depends on the fact that the secondary amino group of ifosphamide is hindered electronically and sterically, while the nucleophilic amino group of cyclophosphamide reacts with the nitrosyl group of sodium nitroprusside molecule, giving a bluish green colour measurable at 708 nm. This colour is used for the determination of cyclophospahmide in the presence of its isomer ifophamide in the range from 0.2 to 1 mg ml−1 with repeatability of 99.2 ± 1.49%. The suggested procedures are applied successfully to pharmaceutical formulations of cyclophosphamide and ifosphamide, and their validities are assessed by applying the standard addition technique. The results obtained by applying the proposed procedures are statistically analyzed and compared with those obtained by adopting the United States Pharmacopoeial method.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.